Organometallic Chemistry Approach to Peptide Tricycles Authors: Nima Adhami, Michael J.P. Rebelo, Rebecca A. Jenkins, Eileen J. Olivares, Rachel R. Ogorzalek Loo, Songrong Qu, Melanie J. Olivares, Reanne J. Coutinho, Evan A. Doud, Tyler A. Kerr, Austin D. Ready, Yueying Wang, Brendan J. Mahoney, Robert T. Clubb, Joseph A. Loo, Jose A. Rodriguez, Alexander M. Spokoyny Published: 2026 ABSTRACT Herein, we demonstrate how Au­(III) organometallic chemistry offers the potential to streamline the generation of constrained peptide tricycles. By leveraging the chemoselectivity and ultrafast kinetics of tetrametallic Au­(III)-based aryl reagents toward cysteine (Cys) bioconjugation, we have constructed a small library of constrained peptide tricycles. These tricycles can be synthesized and isolated in 25–55% yields from various tetracysteine-containing linear peptides. In all cases, tricyclization conversion occurs quantitatively under five min at sub-mM concentrations of the target peptide and proceeds under varied distributions of the four Cys residues in the target peptide sequence. Furthermore, by constraining various linear peptides around the aryl core of tetraphenylethylene, a common solid-state luminogen, we generate fluorescent macrocycles with robust solution-state emissive profiles. We evaluated the innate affinity of these fluorescent hybrid peptides toward cells, finding that they behave as highly selective luminogenic cell markers of cellular debris. Introduction Constrained peptide macrocycles have garnered increased attention in recent years for their role as the next generation of potential therapeutic agents. − These structures, when well-designed, can provide large molecular footprints for efficient interaction with protein surfaces while improving inherent proteolytic instability of the linear peptide congeners. − By rigidifying a linear peptide into a constrained conformation, one can also significantly minimize the degrees of freedom in these systems, thereby increasing target binding of the resulting hybrid peptides. ,− There now exist many synthetic strategies for accessing peptide-based macrocycles (Figure A,B). − ,− Typically, an unprotected peptide containing two or more residues capable of selective reactivity with an abiotic multifunctional linker can be utilized to generate the corresponding polycyclic structure. − In the selection of the reactive amino acid residues, cysteine moieties are particularly attractive as they provide a unique chemical orthogonality given their soft nucleophilic properties. ,,− Specifically, direct S-alkylation ,, and S-arylation ,,,,,− strategies have been extensively utilized for creating various constrained peptide motifs. (A, B) Representative examples of S-alkylation and arylation strategies that yield monocyclic and bicyclic constrained peptides. (C) Illustration of the limitations of common thiol-based macrocyclization reagents toward peptide tricycles. (D) Brief overview of the use cases of Au­(III) organometallic reagents in cysteine bioconjugation chemistry. (E) Graphical representation showcasing the fidelity of various macrocyclization reagents toward generating structural complex hybrid peptide systems. (F) Strategy highlighted in this work, demonstrating the utility of tetrametallic Au­(III) complexes toward the generation of constrained peptide. While the generation of singly or doubly looped constrained peptides have been thoroughly investigated, creating hybrid systems of increasing structural complexity (e.g., tricycles, tetracycles) has proven challenging (Figure C). ,,− As the number of cysteine residues in the linear peptide increases, competition between intramolecular and intermolecular cyclization pathways becomes more profound, limiting the utility of many ubiquitous cysteine conjugation reagents. There is therefore a need for bioconjugation reagents that can be used to generate multilooped peptide macrocycles with a high degree of fidelity. Organometallic Au­(III) chemistry has recently been introduced into the repertoire of cysteine bioconjugation reactions (Figure D). ,,− Beyond the ability to facilitate single site bioconjugation of unprotected peptides and proteins, we recently demonstrated that Au­(III) organometallic reagents can facilitate the synthesis of peptide monocycles and bicycles. We have also shown how densely functionalized triaurated aryl scaffolds can be leveraged to create constrained bicyclic peptides. A team at Bicycle Therapeutics demonstrated an elegant extension on our original work, showcasing the ability to construct bicyclic peptides utilizing various densely functionalized trinuclear Au­(III) aryl scaffolds. The ultrafast kinetic profile and chemoselectivity of Au­(III) organometallic reagents toward cysteine positions this chemistry as unique among its S-arylation and S-alkylation counterparts by facilitating rapid intramolecular cyclization while avoiding off-target reactions with other nucleophilic residues as well as unwanted intermolecular oligomerization pathways that normally hinder other Cys-based macrocyclization strategies. ,,− Constrained peptide tricycles are hybrid systems with inherently greater structural complexity than their two-looped analogue. ,,,,,, The increase in geometric intricacy necessitates macrocyclization reagents capable of facilitating these transformations both rapidly and chemoselectively to avoid byproduct formation observed in other cyclization strategies. To this end, we envisioned leveraging our robust Au­(III) organometallic bioconjugation reagents toward the synthesis of constrained peptide tricycles (Figure E). In this work, we demonstrate how tetrametallic Au­(III) reagents can be leveraged to generate constrained peptide tricycles around several rigid aryl-based scaffolds, under mild aqueous conditions. We further show how using the developed chemistry, that one can incorporate a fluorescent scaffold into the structure of the peptide tricycles (Figure F). By installing a tetraphenylethylene (TPE) scaffold, a commonly utilized solid-state aromatic fluorophore with emissive properties linked to its aggregation induced emission (AIE) profile, − we showcase how the peptide macrocyclization process can rigidify the fluxionality inherent to this molecular system, thereby achieving fluorescent quantum efficiencies in aqueous solutions normally associated with solid-state materials. , Fluorescent cell studies with our luminogenic hybrid peptides showcased the unique ability of this system to act as a highly selective cellular stain of apoptotic bodies. Results and Discussion We commenced our studies by designing and synthesizing a series of tetrametallic Au­(III) reagents. Scaffolds 1a-1c were initially chosen as these contain aryl species linked to central carbon-containing cores of increasing structural complexity methane, ethylene, and benzene. Furthermore, each scaffold was designed to contain an aryl iodide moiety on the para position to the central moiety in order to further derivatize this scaffold with Au­(III) centers. These tetraiodinated aryl-based linkers (1a–1c) were then synthesized and characterized by 1H, 13C­{1H} nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) to confirm their structural composition and purity (see SI Figures S5–S8). Treatment of four equivalents of a (P,N)-supported MeDalPhos Au­(I) complex (1) with 1a–1c individually in the presence of AgSbF6 affords the three primary tetrametallic Au­(III) complexes investigated in this work 2a, 2b, 2c (Figure A). The metalation reactions proceed to completion within 2 h at room temperature, as determined by in situ 31P­{1H} NMR spectroscopy. Disappearance of the 31P­{1H} NMR resonance at ca. 56 ppm and the appearance of the downfield shifted resonance (ca. 74 ppm), corresponding to complete conversion of MeDalPhos-ligated Au­(I)Cl (1) to the corresponding Au­(III) complexes (Figure B). These tetrametallic species can be isolated as air-stable salts with 1H, 13C­{1H}, 31P­{1H} NMR spectroscopic characterization consistent with the proposed structural formulation of 2a–2c. When a solution of 2b, dissolved in dichloromethane and layered with diethyl ether is left for 2 days at room temperature in a vial, diffraction quality single crystals of 2b are obtained. The single crystal X-ray diffraction (XRD) study on 2b confirmed the identity of a tetraphenylethylene core ligated to four distorted tetrahedral Au­(III) site each chelated by a bidentate P,N ligand (Figure C). (A) Illustration of the three tetrametallic Au­(III) reagents that is the subject of this work. (B) 31P­{1H} NMR spectrum of [2a–c] (DCM-d 2, 162 MHz, 25 °C). (C) Solid-state structure of [2c] rendered using OLEX with thermal ellipsoids at 50% probability. Hydrogens and SbF6 – counterions atoms omitted for clarity. Multisite Bioconjugations With complexes 2a-c in hand, we sought out to evaluate the fidelity of our tetrametallic Au­(III) reagents toward multisite bioconjugations. In an effort to determine whether each individual Au­(III) site can engage in a productive S-arylation, we have exposed 2a–c to four equivalents of the model peptide l-glutathione (GSH). This simple and commercially available tripeptide was chosen as it contains both nucleophilic thiol and several amine functionalities. In a model bioconjugation reaction, four equivalents of [3 mM] GSH are mixed with [200 μM] of a tetrametallic linker at room temperature in pH 8.0 TRIS (tris­(hydroxymethyl)-aminomethane) buffered solution of 1:2 H2O:MeCN (Figure A). Within 5 min, the magnetically stirred reaction is complete as evidenced by in situ 31P­{1H} NMR spectroscopy showing full disappearance of the resonance corresponding to the Au­(III) species and the concomitant appearance of the (P,N) ligated Au­(I) complex (ca. 56 ppm). A filtered and diluted aliquot of the reaction mixture also illustrates quantitative conversion to the tetrasubstituted peptide-aryl conjugate, as determined with liquid chromatography–mass spectrometry (LCMS) analysis (Figure B). The crude reaction mixtures of 3a–c can be further purified using reverse-phase high performance liquid chromatography (HPLC), with purity analyzed and confirmed by LCMS. The isolated yields of 65–72% between the three conjugation reactions further demonstrate the selective nature of the Au­(III) mediated S-arylation strategy. The high yields and facile synthesis afforded by these Au­(III) organometallic reagents toward multisite GSH-bioconjugations aided in guiding our investigation into constructing constrained peptide macrocycles. (A) Scheme of the generation of tetrasubstituted glutathione-aryl conjugates [3a–c]. (B) Overlaid LCMS traces of purified [3a–c]. Peptide Tricycles We next leveraged our Au­(III) reagents toward the construction of abiotic constrained peptide tricycles. To develop general macrocyclization conditions, we utilized peptide entry I and complex 2b for optimization studies (see SI Figures S29 and S30). Peptide I is dissolved in 200 mM TRIS buffer at pH 8 (Figure A). A solution of Au­(III) reagent 2b in acetonitrile is then added dropwise to the aqueous peptide solution. After ca. 5 min an aliquot of the crude reaction mixture subjected to LCMS analysis confirms full consumption of the starting peptide substrate and concomitant formation of the constrained peptide tricycle. HPLC purification is then performed on the crude reaction mixture to further isolate the desired macrocycle. Definitive evidence of successful peptide constrainment through direct S-arylation was determined via tandem mass spectrometry (MS/MS) analysis of purified Ib. An aliquot of this purified substrate was subjected to MS/MS using a Q Exactive quadrupole-orbitrap mass spectrometer. Analysis of the fragmented constrained peptide tricycle confirmed both successful macrocyclization around the tetraphenylethylene core as well as demonstrating that our Au­(III) organometallic reagent only targeted the desired cysteine residues and no other nucleophilic sites such as amines, amides, or hydroxy moieties (see SI Figures S66–S71). Additionally, due to the ultrafast kinetic profile of Au­(III)-mediation S-arylation chemistry, as measured in our group’s prior art, no reducing agent is needed to preclude disulfide formation. ,,− (A) Synthetic scheme of a tetraphenylethylene anchored Au­(III) mediated peptide tricycle formation, illustration of tricycle Ib using PyMOL, and LCMS data of the purified conjugate. (B) Substrate scope of Au­(III)-mediated peptide tricyclization across a series of tetracysteine peptide substrates and aryl scaffolds [a–e]. Underlined residues denote the Cys residues involved in macrocyclization. Reaction not performed are denoted by “–”. We then decided to probe whether the conditions favorable for the formation of tricycle Ic can be leveraged toward generating a library of constrained peptide macrocycles with different aryl scaffolds. To this end, peptides with different residue identities, spacings between reactive cysteines, and electronic properties including sulfur-containing methionine were selected (Figure B and SI Figures S57 and S60). All macrocyclization reactions proceeded to completion under identical conditions that were developed and optimized for tricycle Ib as determined by LCMS analysis of the crude reaction aliquots. HPLC purification of the crude reaction mixtures was used to determine the isolated yields of these reactions, which varied from 25 to 55%. Across this series of macrocyclizations, isolated yields increased with peptide length, consistent with reduced steric congestion between the peptide backbone and the aryl core. All hybrid peptide tricycles displayed the formation of two dominant regioisomers. Although definitive structural assignment of individual regioisomers by X-ray crystallography or NMR spectroscopy proved challenging, the two products were readily distinguished by LCMS based on intrinsic polarity differences, enabling clean separation and isolation by reverse-phase C18 HPLC. Importantly, no evidence of intermolecular oligomerization was detected by LCMS analysis of crude reaction mixtures. The consistent formation of only two primary regioisomers across all macrocyclization reactions performed, underscores three defining advantages of the tetrametallic Au­(III) platform: ultrafast S-arylation kinetics, a rigid aryl scaffold, and well-defined spatial separation between reactive Au­(III) centers. Together, these features synergize with tetracysteine peptides to promote efficient tricyclization while suppressing excessive regioisomer formation. To rigorously test this hypothesis, we conducted a systematic series of cyclization experiments using structurally distinct tetracysteine peptides and cyclization reagents. Three cyclization reagents were evaluated: Au­(III) reagents 2b and 2d, and a commonly used small-molecule tricyclization reagent 1,2,4,5-tetrakis­(bromomethyl)­benzene (1f) (see SI Figure S54). Complex 2b features a rigid internal aryl scaffold, whereas 2d, which was prepared according to following previously described procedures, bears a structurally flexible, nonplanar aryl core resulting from the inclusion of methylene oxy spacer in between the phenyl rings of the complex (Figure B and SI Figures S9, S10, S20, and S21). In contrast, 1f is a conformationally flexible organic linker that undergoes significantly slower Cys functionalization relative to Au­(III)-mediated S-arylation (∼101 M–1 s–1 vs ∼ 104 M–1 s–1). Three peptides spanning a wide range of lengths and flexibilities were examined: peptide VI, a compact 12-mer with 2 × 2 × 2 cysteine spacing; peptide I, a 15-mer with 3 × 3 × 3 spacing; and peptide VIII, a 24-mer with 6 × 6 × 6 spacing between reactive sites. Notably, despite the high symmetry of tetraphenylmethane-based scaffolds, regioisomer products can still arise due to asymmetry within the peptide chain, leading to the generation of several distinct macrocyclic products upon ligation to the tetrahedral core. This selection of cyclization reagents and peptides enabled a direct assessment of how conformational freedom and peptide length influence regioisomer formation across different cyclization platforms. Cyclization with the rigid and planar tetrametallic complex 2b with peptide VI afforded two dominant products with 3 detectable isomer byproducts, albeit at a combined yield of <1% (see SI Figure S55). The formation of tricycle Ib, however, while showcasing the typical two dominant products, was also accompanied by 4 minor isomers at a < 10% combined yield (see SI Figure S56). When reacting 2b with peptide VIII, a 24-mer and our largest peptide, we observed a complex isomer distribution, showcasing a breakdown in regiocontrol in our Au­(III) platform only when using sufficiently large peptide substrates (see SI Figure S57). In contrast, cyclizations using the flexible analogue 2d resulted in substantially broader product distributions for all peptides examined, yielding 5, 10, and 24 detectable isomers for peptides VI, I, and VIII, respectively (see SI Figures S58–S60). This pronounced loss of regioisomer control highlights the critical role of scaffold rigidity in constraining productive macrocyclization pathways. Finally, to further emphasize the importance of both scaffold preorganization and rapid reaction kinetics, the commonly employed tricyclization reagent 1f was evaluated under comparable reaction conditions. In all cases, reactions with 1f produced the highest degree of isomer distribution observed, yielding 10, 12, and 24 regioisomers for peptides VI, I, and VIII, respectively (see SI Figures S61–S63). Collectively, these results demonstrate that structural rigidity and preorganization, in addition to ultrafast Au­(III)-mediated kinetics, are essential design elements for achieving controlled peptide tricyclization. Minimizing isomer distribution, particularly for large, unmodified peptides, has remained a persistent challenge in macrocyclization chemistry. ,,− ,− In this context, the Au­(III)-based approach compares favorably against conventional strategies such as benzyl halide routes, which often generate complex and poorly controlled product distributions. Collectively, these results underscore the capacity of tetrametallic Au­(III) reagents to address long-standing limitations in peptide macrocyclization by enabling robust cyclization with tightly controlled regioisomer distributions. Many bioconjugation reagents exhibit diminished functionality outside of their narrow pH window, thus limiting their general utility. In an effort to further investigate the reactive capabilities of Au­(III) macrocyclization reagents, bioconjugations at a broad range of pH conditions were conducted. Peptide I was chosen as it has favorable distribution of nucleophilic residues other than cysteine as well as an isoelectric point that aids in solubilizing the substrate in both acidic and basic media. The Au­(III) complex, 2b, dissolved in acetonitrile, was added dropwise to the peptide solutions at pH 0.5 and 14. In both cases, the macrocyclization reactions proceeded to completion within ca. 5 min as determined by LCMS (see SI Figures S64–S66) and the peptides were isolated and purified in (42% and 46%) yields, respectively. Ultimately, macrocycles of peptides I–VIII were synthesized demonstrating the ability to generate tricycles with varying loop sizes and amino acid compositions. These experiments highlight how Au­(III) chemistry enables peptide macrocyclizations under a broad range of pH conditions. Fluorescence Many tetraphenylethylene molecules and their derivatives exhibit solid-state fluorescent properties. , The emission profiles in these systems often emerge from the π-π interactions resulting from the intermolecular aggregation of multiple molecules. ,, This aggregation induced emission (AIE) phenomenon has been successfully observed in multiple classes of materials ranging from hybrid nanoparticles to polymers. − To achieve solution-state fluorescence, however, restricting rotation of the phenyl rings bound to the central ethylene moiety is critical. ,, Known as restriction of intramolecular rotation (RIR), this process limits the fluxionality of the phenyl ring arms and aids in efficient π-π stacking in solution. We theorized that our macrocyclic platform could facilitate RIR and achieve significant solution-state fluorescence. Au­(III) reagent 2b represents an enticing TPE-based scaffold for the incorporation of a fluorophore within the hybrid structure of a polymacrocyclized peptide. To investigate this possibility, peptide I was reacted with 2b using the standard macrocyclization conditions at pH 8. The reaction mixture solution instantaneously produced a visually observed fluorescent emission under the irradiation with a UV-lamp at 254 nm. The purified tricycle Ib was then lyophilized and resuspended in dimethylformamide (DMF), before it was subjected to UV–vis and fluorescence spectroscopic measurements (Figure A). Importantly, this tricycle exhibits a well-defined emission at 470 nm with a quantum yield of 11%. Control experiments were performed aimed at highlighting the importance of the macrocyclization process in achieving fluorescence, when no observable emission is seen for peptides that do not contain a TPE core as well as Au-based byproducts or precursors (see SI Table S1). We then evaluated the absorbance and emission profiles of several TPE anchored macrocycles as a function of peptide chain length. Peptides III, V, VI, which are 14, 13, and 12 amino acid substrates, respectively, were subjected to macrocyclization (Figure B). Upon successfully isolating and evaluating the absorbance and emissive properties of IIIb, Vb, and VIb, it was observed that rigidification of shorter peptides around the TPE scaffold leads to a nearly 6-fold increase in fluorescent quantum yield. As such, tricycle VIb exhibits a quantum yield of 65% which is on par with several other record-breaking metrics from nonbiological RIR systems. − Importantly, in all cases, excited state lifetimes for the macrocyclic peptides remain in the low nanosecond regime. Furthermore, this approach represents the first example of a natural biomolecule used to solely constrain a TPE moiety to induce fluorescence. (A) Absorbance (dotted line) and emission (solid line) spectra of four representative constrained peptide tricycles anchored around a TPE core. Structures illustrated with PyMOL. (B) Quantum yield (ϕ) and lifetime (ns) table of four representative peptide tricycles substrates. (C) Fluorescent, brightfield, and merged channels of polyLys-VIb incubated with HEK cells at 25 μM after treatment of 10% DMSO for 60 min. Scale bar: 100 μm. Cell Studies Due to their unique photophysical properties, tetraphenylethylene (TPE)-derived molecular systems have emerged as versatile platforms for the development of fluorescent sensors capable of detecting and imaging biological targets. − Typically, these systems are decorated with tailored chemical linkers that facilitate binding to specific biomolecules, resulting in a fluorescent readout within cellular environments. − Despite significant advancements in the field, this study represents the first demonstration of a macrocyclized hybrid peptide that integrates a TPE core with a biomolecular scaffold, enabling fluorescence in aqueous media. Building upon this foundational work, we hypothesized that TPE-anchored peptide tricycles could serve as fluorescent probes that report directly on their cellular interactions. To evaluate this hypothesis, we synthesized tricycle VIb, both with and without a poly-l-lysine (polyLys) tag (see SI Figure S52). The selected tag was incorporated into the macrocycle architecture in an effort to improve aqueous solubility and promote cellular internalization. Human embryonic kidney (HEK293T) cells were seeded in 96-well plates in growth media, followed by the addition of peptide tricycle VIb or polyLys-VIb at varying concentrations (1–50 μM, in DMSO). Due to the limited aqueous solubility of both macrocycles, stock solutions were prepared in neat DMSO prior to dilution into the cell culture media. The cells were subsequently incubated for 60 min to allow uptake and visualization via fluorescence microscopy. Following a thorough washing of any unbound macrocycle from each well, the culture plate was evaluated in a widefield fluorescent microscope. In the 405 nm DAPI channel, polyLys-VIb exhibited a noticeable emissive profile (see SI Figure S73) compared to tricycle VIb, which bears no such tag. Notably, we observed a lack of cellular internalization, with fluorescent puncta ascribed to cellular blebs or fragments of variable sizes. Furthermore, unstained cells had begun exhibiting morphological hallmarks of apoptosis, including cell shrinkage and abiotic geometries, when viewed in the trans brightfield channel. This is consistent with the peptides larger than 1000 Da, whether macrocyclized or in their native linear state, facing significant difficulties internalizing into cells, regardless of amino acid composition. − These discoveries prompted the hypothesis that the tricycles either selectively stain apoptotic cells or bind to cellular debris, such as apoptotic blebs, formed during macrocycle incubation. To test this, we repeated the fluorescence assay under apoptosis-inducing conditions while coincubating our cells with a LIVE/DEAD cell stain. This experimental design allowed us to differentiate between fluorescence originating from macrocycles internalized into live cells, dead cells, or apoptotic debris. HEK cells were pretreated with 10% DMSO for 30 min to induce apoptosis, followed by the addition of tricycle VIb and polyLys-VIb (see SI Figures S74 and S75). Interestingly, wells incubated with VIb now display an increase in detectable fluorescence, albeit to a limited degree relative to polyLys-VIb. Under these conditions, fluorescence was again exclusively observed in cellular blebs, with neither live nor dead cells showcasing detectable emission. These results suggest that TPE-anchored tricycles selectively stain apoptotic debris rather than intact cells. To further validate these findings, the LIVE/DEAD cell stain assay was repeated at a fixed macrocycle concentration of 25 μM, incorporating a temporal component. PolyLys-VIb and VIb fluorescence was monitored as a function of various incubation times (5–60 min) (Figure C and SI Figures S76 and S77). After an initial few minute’s elapses, the fluorescence intensity peaks, and then importantly, remains constant. This suggests that polyLys-VIb binds to preexisting apoptotic blebs rather than itself inducing apoptosis. A cell assay was performed to evaluate the emissive response of polyLys-VIb and VIb following incubation with HEK cells pretreated with increasing concentrations of DMSO (see SI Figures S78–S80). A concentration-dependent increase in fluorescent apoptotic bleb formation was observed upon increasing DMSO. Importantly, this response was attributable to vehicle-induced apoptosis rather than toxicity arising from the peptide tricycles themselves. To further confirm the absence of intrinsic cytotoxicity in our peptide tricycles, an MTT cell viability assay was performed using tricycle VIb, polyLys-VIb, and a water-soluble macrocycle VIe. Following established synthetic protocols, described vide supra, tricycle VIe was accessed through 2e, which bears a Td-symmetric tetraphenylborate aryl core (Figure B and SI Figures S11–S13, S22–S24, and S53). Tetraphenylborate salts, particularly lithium derivatives, are known to exhibit exceptional aqueous solubility, and we reasoned that incorporation of this scaffold would impart water-soluble properties to the resulting peptide tricycle. , The reaction mixture of VIe was then purified on a reverse-phase C18 HPLC, and dissolved in water without the need for any organic cosolvent. This design enabled fully aqueous handling and eliminated the need for DMSO vehicle in cellular studies, which is important given that DMSO itself can induce apoptosis, even at low concentrations. Importantly, this observation suggests that the intrinsic solubility profile these macrocycles is strongly influenced by the physicochemical properties of the internal aryl core rather than solely the peptide sequence itself. This macrocycle was then evaluated alongside VIb and polyLys-VIb in a MTT cell viability assay (see SI Figure 81). A 25 μM aqueous solution of VIe displayed a cell viability profile nearly identical to that of nontreatment (water vehicle) control. Similarly, 25 μM solutions of VIb and polyLys-VIb prepared in DMSO exhibited toxicity profiles comparable to the DMSO control. Collectively, these results indicate that the constrained peptide tricycles do not induce measurable cytotoxicity under standard cell culture conditions, and that observed reductions in cell viability arise from the vehicle rather than the macrocyclic scaffolds themselves. Finally, these findings highlight TPE-anchored peptide tricycles as selective probes for imaging apoptotic cellular debris. In contrast to poly-l-lysine–modified peptides, which are commonly employed as cell-penetrating carriers, the TPE-based tricycles described here do not undergo detectable uptake into intact cells, effectively functioning as “stealth” macrocycles capable of selectively reporting on apoptotic processes without perturbing cell viability. Conclusions In summary, we have developed a robust Au­(III)-mediated platform for the chemoselective intramolecular S-arylation of cysteine residues, enabling the efficient construction of constrained peptide tricycles. This approach utilizes tetrametallic Au­(III) reagents to achieve rapid and selective macrocyclization of tetracysteine-containing peptides, yielding structurally complex tricyclic peptides under mild aqueous conditions. Our studies demonstrated that the Au­(III)-based macrocyclization process is effective across a wide pH range and produce little to no regioisomer byproducts while utilizing tetracysteine peptide substrates as long as 15 residues, which is critical for potential therapeutic applications of macrocycles. Additionally, this platform was leveraged to modulate the emissive profiles of a solid-state fluorophore, tetraphenylethylene, yielding hybrid peptide tricycles with tunable fluorescent properties in solution. The unique photophysical properties of TPE-anchored peptide tricycles enabled successful cellular imaging, showcasing their promise as fluorescent probes for staining cellular debris. This work underscores the versatility and efficiency of Au­(III) chemistry in biomolecular macrocyclization chemistry, providing new avenues to create new hybrid biomaterials. More broadly, this work powerfully highlights how organometallic chemistry can enable the precise construction of sophisticated hybrid biomolecular architectures, demonstrating its unparalleled potential to transform the way we design and manipulate complex biological systems. Importantly, the Au­(III)-based chemistry employed in these studies exhibits minimal background reactivity compared to traditional cysteine modification approaches and, when combined with its exceptional kinetic efficiency, provides a uniquely powerful platform for highly selective and effectively “backgroundless” peptide macrocyclization. Supplementary Material